View as a Web Page NIST Puts New Biopharmaceutical Quality Control Method to the Test A new method for monitoring biopharmaceutical product quality was recently put to the test by The National Institute of Standards and Technology (NIST) and 28 laboratories representing the biopharmaceutical industry, instrument and software vendors, and the federal government. The  results of this interlaboratory study were recently published in the Journal of the American Society for Mass Spectrometry. The new multi-attribute method, or MAM, is an emerging, mass spectrometry-based technique for monitoring product quality and detecting multiple types of potential impurities in biopharmaceutical products with a single-step test. Read More

Connect with us Received this email from a friend? Subscribe here.   Privacy Policy You are subscribed to receive updates from the National Institute of Standards and Technology (NIST). Subscriber services: Manage Preferences  |  Unsubscribe  |  Help

 

---

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. Technical questions? Contact inquiries@nist.gov. (301) 975-NIST (6478). This service is provided to you at no charge by National Institute of Standards and Technology (NIST). 100 Bureau Drive, Stop 1070 · Gaithersburg, MD 20899 · 301-975-6478